×
Alcon Common Stock Net 2019-2024 | ALC
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Alcon common stock net for the quarter ending September 30, 2024 was
$0.020B
, a
0% increase
year-over-year.
Alcon common stock net for 2023 was
$0.02B
, a
0% decline
from 2022.
Alcon common stock net for 2022 was
$0.02B
, a
0% decline
from 2021.
Alcon common stock net for 2021 was
$0.02B
, a
0% decline
from 2020.
View More
Alcon Common Stock Net 2019-2024 | ALC
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Alcon common stock net for 2023 was
$0.02B
, a
0% decline
from 2022.
Alcon common stock net for 2022 was
$0.02B
, a
0% decline
from 2021.
Alcon common stock net for 2021 was
$0.02B
, a
0% decline
from 2020.
Related Stocks
Company Name
Market
Cap
Thermo Fisher Scientific (TMO)
$214.1B
Intuitive Surgical (ISRG)
$211.1B
Edwards Lifesciences (EW)
$41.2B
IQVIA Holdings (IQV)
$35.8B
IDEXX Laboratories (IDXX)
$34.3B
DexCom (DXCM)
$33B
Waters (WAT)
$24B
STERIS (STE)
$20.7B
SONOVA HOLDING (SONVY)
$19.7B
Hologic (HOLX)
$15.7B
Fresenius Medical Care AG KGaA (FMS)
$13.5B
Globus Medical (GMED)
$12.4B
Sysmex ADR (SSMXY)
$11.7B
Penumbra (PEN)
$10.1B
Masimo (MASI)
$9.2B
Glaukos (GKOS)
$8.6B
Teleflex (TFX)
$8.4B
Integer Holdings (ITGR)
$4.7B
Inari Medical (NARI)
$4.7B
PROCEPT BioRobotics (PRCT)
$4B
Veracyte (VCYT)
$3.1B
Nihon Kohden (NHNKY)
$2.7B
LivaNova (LIVN)
$2.6B
Tandem Diabetes Care (TNDM)
$2.3B
Elekta AB (EKTAY)
$2.2B
TransMedics (TMDX)
$1.9B
Integra LifeSciences Holdings (IART)
$1.9B
Alphatec Holdings (ATEC)
$1.6B
Artivion (AORT)
$1.3B
RxSight (RXST)
$1.2B